Qiagen N.V. (QGEN)
NYSE: QGEN · IEX Real-Time Price · USD
41.55
-0.23 (-0.55%)
At close: Jul 19, 2024, 4:00 PM
41.81
+0.26 (0.63%)
Pre-market: Jul 22, 2024, 6:52 AM EDT
Qiagen Employees
Qiagen had 5,967 employees as of December 31, 2023. The number of employees decreased by 211 or -3.42% compared to the previous year.
Employees
5,967
Change (1Y)
-211
Growth (1Y)
-3.42%
Revenue / Employee
$324,905
Profits / Employee
$56,467
Market Cap
9.22B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5,967 | -211 | -3.42% |
Dec 31, 2022 | 6,178 | 150 | 2.49% |
Dec 31, 2021 | 6,028 | 418 | 7.45% |
Dec 31, 2020 | 5,610 | 514 | 10.09% |
Dec 31, 2019 | 5,096 | 144 | 2.91% |
Dec 31, 2018 | 4,952 | 264 | 5.63% |
Dec 31, 2017 | 4,688 | 4 | 0.09% |
Dec 31, 2016 | 4,684 | 125 | 2.74% |
Dec 31, 2015 | 4,559 | 220 | 5.07% |
Dec 31, 2014 | 4,339 | 324 | 8.07% |
Dec 31, 2013 | 4,015 | 16 | 0.40% |
Dec 31, 2012 | 3,999 | 61 | 1.55% |
Dec 31, 2011 | 3,938 | 351 | 9.79% |
Dec 31, 2010 | 3,587 | 92 | 2.63% |
Dec 31, 2009 | 3,495 | 454 | 14.93% |
Dec 31, 2008 | 3,041 | 379 | 14.24% |
Dec 31, 2007 | 2,662 | 708 | 36.23% |
Dec 31, 2006 | 1,954 | 365 | 22.97% |
Dec 31, 2005 | 1,589 | 267 | 20.20% |
Dec 31, 2004 | 1,322 | -231 | -14.87% |
Dec 31, 2003 | 1,553 | -98 | -5.94% |
Dec 31, 2002 | 1,651 | 94 | 6.04% |
Dec 31, 2001 | 1,557 | 242 | 18.40% |
Dec 31, 2000 | 1,315 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walgreens Boots Alliance | 331,000 |
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Solventum | 20,098 |
AptarGroup | 13,800 |
Bruker | 9,707 |
Bio-Rad Laboratories | 8,030 |
Exact Sciences | 6,600 |
QGEN News
- 19 days ago - QIAGEN N.V. to release results for Q2 2024 and hold webcast - GlobeNewsWire
- 24 days ago - QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children - GlobeNewsWire
- 5 weeks ago - QIAGEN announces 2028 strategy for solid profitable growth - GlobeNewsWire
- 5 weeks ago - QIAGEN's software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs - GlobeNewsWire
- 5 weeks ago - QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth - GlobeNewsWire
- 5 weeks ago - QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance - GlobeNewsWire
- 6 weeks ago - QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period - GlobeNewsWire
- 6 weeks ago - QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe - GlobeNewsWire